From: Neurologic outcome of VZV encephalitis one year after ICU admission: a multicenter cohort study
Variables | Patients |
---|---|
Neurocritical care, n (%) | |
Acyclovir | 55 (100%) |
High dose of steroids | 4 (7%) |
Anticonvulsant therapy | 12 (22%) |
Life-sustaining therapies | |
Invasive mechanical ventilation (IMV), n (%) | 46 (84%) |
Duration of IMV, days, median [IQR] | 13 [3–0] |
Vasopressors, n (%) | 22 (40%) |
Renal replacement therapy, n (%) | 15 (27%) |
Outcome | |
ICU mortality, n (%) | 14 (25%) |
ICU length of stay, days, median [IQR] | 15 [6–38] |
Hospital length of stay, days, median [IQR] | 35 [17–55] |
One-year mortality | 18 (33%) |